Neuroendocrine differentiation prostate cancer: From lab to bedside

被引:41
|
作者
Cindolo, Luca
Cantile, Monica
Vacherot, Francis
Terry, Stephane
de la Taille, Alexandre
机构
[1] G Rummo Hosp, Urol Unit, I-82100 Benevento, Italy
[2] Univ Naples Federico II, Sch Med, Dept Clin & Expt Med, Naples, Italy
[3] INSERM, Fac Med, E 0337, F-75654 Paris 13, France
[4] Univ Paris 12, Fac Med, Paris, France
[5] Grp Hosp Henri Mondor, Serv Urol, APHP, Creteil, France
关键词
prostate cancer; neuroendocrine differentiation; chromogranin A; NeuroD1; LNCaP;
D O I
10.1159/000109711
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objectives: To discuss the current knowledge on induction, production, sustenance and promotion of neuroendocrine differentiation in human prostate cancer. Methods: Review literature using PubMed search and scientific journal Results: Morphological evidence explains some functional relationship between neuroendocrine and surrounding cells. Transdifferentiation phenomenon and new biochemical pathways could be included in the development of androgen independence and prostate progression. Conclusion: Multiple evidence seems to that a synergistic functional network between epithelial PSA secretory cells and neuroendocrine intraprostatic system is the main trigger for the induction and sustenance of neuroendocrine differentiation. The development of new antineoplastic molecules should consider the multiple of the intercellular network. Copyright (c) 2007 S. Karger AG, Basel.
引用
收藏
页码:287 / 296
页数:10
相关论文
共 50 条
  • [41] The Correlation between PSCA Expression and Neuroendocrine Differentiation in Prostate Cancer
    Xiang, Qian
    Zhu, Zhiguo
    Luo, Lianmin
    Wang, Jiamin
    Liu, Yangzhou
    Deng, Yihan
    Zhou, Mingda
    Zhao, Zhigang
    BIOMED RESEARCH INTERNATIONAL, 2020, 2020
  • [42] SIRT1 contributes to neuroendocrine differentiation of prostate cancer
    Ruan, Lin
    Wang, Lei
    Wang, Xiaosong
    He, Ming
    Yao, Xiaoguang
    ONCOTARGET, 2018, 9 (02) : 2002 - 2016
  • [43] Neuroendocrine differentiation in prostate cancer: a sheep in wolf's clothing?
    Slovin, SF
    NATURE CLINICAL PRACTICE UROLOGY, 2006, 3 (03): : 138 - 144
  • [44] From Bench to Bedside: Immunotherapy for Prostate Cancer
    Tse, Brian Wan-Chi
    Jovanovic, Lidija
    Nelson, Colleen Coyne
    de Souza, Paul
    Power, Carl Andrew
    Russell, Pamela Joan
    BIOMED RESEARCH INTERNATIONAL, 2014, 2014
  • [45] Prognostic effect of neuroendocrine differentiation in prostate cancer: A critical review
    Surcel, Cristian I.
    van Oort, Inge M.
    Sooriakumaran, Prasanna
    Briganti, Alberto
    De Visschere, Peter J. L.
    Futterer, Jurgen J.
    Ghadjar, Pirus
    Isbarn, Hendrik
    Ost, Piet
    van den Bergh, Roderick C. N.
    Yossepowitch, Ofer
    Giannarini, Gianluca
    Ploussard, Guillaume
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2015, 33 (06) : 265.e1 - 265.e7
  • [46] Elucidating transcriptional dynamics in neuroendocrine differentiation of advanced prostate cancer
    Chen, Chia-Chun
    Song, Kai
    Tran, Wendy
    Obusan, Matthew
    Sugimoto, Tyler
    Sheu, Katherine
    Cheng, Donghui
    Varuzhanyan, Grigor
    Wang, Liang
    Ta, Lisa
    Mao, Zhiyuan
    Bangayan, Nathanael
    Park, Jung-Wook
    Graerber, Thomas
    Witte, Owen
    CANCER RESEARCH, 2022, 82 (12)
  • [47] Neuroendocrine differentiation in prostate cancer: an unrecognized and therapy resistant phenotype
    Bonkhoff, H
    Fixemer, T
    PATHOLOGE, 2005, 26 (06): : 453 - 460
  • [48] ACTH-secreting metastatic prostate cancer with neuroendocrine differentiation
    Hassan, Bashar
    Yazbeck, Yara
    Akiki, Vanessa
    Salti, Ibrahim
    Tfayli, Arafat
    BMJ CASE REPORTS, 2022, 15 (12)
  • [49] MUC1 induces neuroendocrine differentiation of prostate cancer
    Yasumizu, Yota
    Kosaka, Takeo
    Hongo, Hiroshi
    Oya, Mototsugu
    CANCER SCIENCE, 2022, 113 : 1595 - 1595
  • [50] MicroRNAs in treatment-induced neuroendocrine differentiation in prostate cancer
    Akoto, Theresa
    Bhagirath, Divya
    Saini, Sharanjot
    CANCER DRUG RESISTANCE, 2020, 3 (04) : 804 - 818